Monitoring of Xenograft Tumor Growth and Response to Chemotherapy by Non-Invasive In Vivo Multispectral Fluorescence Imaging

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Caysa, Henrike ^a   Hoffmann, Stefan ^a   Luetzkendorf, Jana ^a   Mueller, Lutz Peter ^a   Unverzagt, Susanne ^a   Mäder, Karsten ^a   Mueller, Thomas ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DSRED2; ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCENCE PROTEIN; FLUOROURACIL; IRINOTECAN; LENTIVIRUS VECTOR; MPLUM; PROTEIN; TURBOFP635; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CANCER CHEMOTHERAPY; CELL CLONE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG RESPONSE; EXPERIMENTAL DESIGN; FLUORESCENCE; FLUORESCENCE IMAGING; GENETIC TRANSDUCTION; GERM CELL TUMOR; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MEASUREMENT; MONITORING; MOUSE; MULTISPECTRAL FLUORESCENCE IMAGING; NON INVASIVE MEASUREMENT; NONHUMAN; SIGNAL PROCESSING; SINGLE DRUG DOSE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION; HUMANS; LUMINESCENT PROTEINS; MALE; MICE; MICE, NUDE; NEOPLASMS, GERM CELL AND EMBRYONAL; OPTICAL IMAGING; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84868108266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047927     Document Type: Article

References (31)

1. Bibby MC, (2004) Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40: 852-857.
2. Kerbel RS, (2003) Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biol Ther 2: S134-S139.
3. Kubota T, (1994) Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem 56: 4-8.
4. Hoffman RM, (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359.
5. Gros SJ, Dohrmann T, Peldschus K, Schurr PG, Kaifi JT, et al. (2010) Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model. Int J Cancer 126: 2671-2681.
6. Hoffman RM, (2005) The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 5: 796-806.
7. Hoffman RM, (2009) Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins. Clin Exp Metastasis 26: 345-355.
8. Levenson RM, Lynch DT, Kobayashi H, Backer JM, Backer MV, (2008) Multiplexing with multispectral imaging: from mice to microscopy. ILAR J 49: 78-88.
9. Levenson RM, Lynch DT, Mansfield JR, (2009) Mice to microscopy: fluorescence in vivo and ex vivo imaging of the same animal. BioTechniques Protocol Guide 2009: 35.
10. Mansfield JR, Gossage KW, Hoyt CC, Levenson RM, (2005) Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging. J Biomed Opt 10: 41207.
11. Bouvet M, Hoffman RM, (2009) Clinically-relevent orthotopic metastatic models of pancreatic cancer imageable with fluorescent genetic reporters. Minerva Chir 64: 521-539.
12. Hasegawa S, Yang M, Chishima T, Miyagi Y, Shimada H, et al. (2000) In vivo tumor delivery of the green fluorescent protein gene to report future occurrence of metastasis. Cancer Gene Ther 7: 1336-1340.
13. Tam JM, Upadhyay R, Pittet MJ, Weissleder R, Mahmood U, (2007) Improved in vivo whole-animal detection limits of green fluorescent protein-expressing tumor lines by spectral fluorescence imaging. Mol Imaging 6: 269-276.
14. Winnard PT, Kluth JB, Raman V, (2006) Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia 8: 796-806.
15. Yang M, Baranov E, Jiang P, Sun FX, Li XM, et al. (2000) Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci U S A 97: 1206-1211.
16. Filonov GS, Piatkevich KD, Ting L, Zhang J, Kim K, et al. (2011) Bright and stable near-infrared fluorescent protein for in vivo imaging Nat Biotechnol. 29: 757-761.
17. Leblond F, Davis SC, Valdes PA, Pogue BW, (2010) Pre-clinical whole-body fluorescence imaging: review of instruments, methods and applications. J Photochem Photobiol B 98: 77-94.
18. Luker GD, Luker KE, (2008) Optical imaging: current applications and future directions. J Nucl Med 49: 1-4.
19. Sandhu GS, Solorio L, Broome A, Salem N, Kolthammer J, et al. (2010) Whole animal imaging. Wiley Interdiscip Rev Syst Biol Med 2: 398-421.
20. Shcherbo D, Merzlyak EM, Chepurnykh TV, Fradkov AF, Ermakova GV, et al. (2007) Bright far-red fluorescent protein for whole-body imaging. Nat Methods 4: 741-746.
21. Stell A, Belcredito S, Ramachandran B, Biserni A, Rando G, et al. (2007) Multimodality imaging: novel pharmacological applications of reporter systems. Q J Nucl Med Mol Imaging 51: 127-138.
22. Bouvet M, Spernyak J, Katz MH, Mazurchuk RV, Takimoto S, et al. (2005) High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Res 65: 9829-9833.
23. Choy G, O'Connor S, Diehn FE, Costouros N, Alexander HR, et al. (2003) Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. BioTechniques 35: 1022-1026, 1028-1030.
24. Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, et al. (2002) Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 62: 1534-1540.
25. Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, et al. (2003) A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113: 151-160.
26. Casper J, Schmoll HJ, Schnaidt U, Fonatsch C, (1987) Cell lines of human germinal cancer. Int J Androl 10: 105-113.
27. Luetzkendorf J, Mueller LP, Mueller T, Caysa H, Nerger K, et al. (2010) Growth inhibition of colorectal carcinoma by lentiviral trail-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. J Cell Mol Med 14: 2292-2304.
28. Brown H, Prescott R (1999) Applied mixed models in medicine. New York: John Wiley and Sons Ltd.
29. Jöbsis FF, (1977) Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters Science. 198: 1264-1267.
30. Weissleder R, (2001) A clearer vision for in vivo imaging Nat Biotechnol. 19: 316-317.
31. Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, et al. (2009) Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 324: 804-807.